Efficacy and safety of rivaroxaban in patients with inferior vena cava filter placement without anticoagulation contraindications (EPICT): a prospective randomised controlled trial study protocol
Guardado en:
Autores principales: | Bin Gao, Li Yin, Wei Han, Libin Zhang, Miaomiao Li, Yuefeng Zhu, Zhenyu Shi, Wan Zhang, Lubin Li, Zhengdong Fang, Guangwei Yang, Linjun Wang, Xueying Ke, Jianing Yue, Zheng Gu, Zhenjie Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc06261ff4df4381a6c15e946f5c744d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation
por: Nicola Mumoli, et al.
Publicado: (2021) -
Troubleshooting during pacemaker implant in persistent left superior vena cava with absence of right superior vena cava (isolated persistent left superior vena cava)
por: Mahmadulla Razi, et al.
Publicado: (2016) -
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
por: Jana Úlehlová, et al.
Publicado: (2021) -
Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban and Apixaban Therapy by Novel Automated Thrombelastography
por: Ramin Artang, et al.
Publicado: (2021) -
Insights Into Endovascular Management of Superior Vena Cava Obstructions
por: Alexandre Ponti, et al.
Publicado: (2021)